This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Monsanto CTO Robb Fraley Defines New Growth Layers For Company's R&D Pipeline





ST. LOUIS, May 23, 2012 /PRNewswire/ -- Monsanto's (NYSE: MON) pipeline offers rich growth layers beyond breeding and biotechnology that add incremental growth opportunities going forward, Chief Technology Officer Robb Fraley, Ph.D., told investors today at the Goldman Sachs Basic Materials Conference 2012.  Fraley discussed new technologies with the potential to create real commercial value in Monsanto's pipeline, including the expansion of the Integrated Farming Systems portfolio and the announcement of a new agricultural biologicals platform featuring BioDirect technology, which represents Monsanto's first step into biological products.  He also touched on emerging global opportunities, highlighting the company's capital investment in Central and Eastern Europe as well as the continued ascension of agriculture in Brazil and Argentina, all of which are expected to drive Monsanto's growth over the next several years.

"Our pipeline has evolved significantly from where it was just a few years ago and today it is more exciting and robust than ever," Fraley said.  "Not since we developed the first Roundup Ready® trait have we seen such promising categories of value emerging from our pipeline.  We're exploring new areas of technology and new areas of the world, and all roads lead to opportunity for both Monsanto and our farmer customers as we work together to improve yields."

Monsanto Introduces Ag Biologicals Platform, BioDirect Technology

Fraley introduced the latest addition to the company's R&D pipeline, early development of ag biological products through Monsanto's new BioDirect technology.  BioDirect brings Monsanto's expertise in plant genomics to chemistry for the first time, enabling products that could provide new options for sustainable pest or virus control. 

Agricultural biologicals are typically topical or seed treatment products that are produced from natural materials and used to complement or replace agricultural chemical products, Fraley said.  These products make up a growing market segment, Fraley noted, and today represent roughly $1.7 billion in sales each year.  

Fraley said BioDirect is a natural extension of Monsanto's work in advanced breeding and biotechnology, as it draws on an extensive knowledge of genomics.  The BioDirect technology utilizes the application of molecules that are in nature, like RNA, to diminish the production of specific proteins in the target organism.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs